---
title: "Seroepidemiologische Studie zur SARS-CoV2-Infektion bei Schulkindern in
  Bogota, Kolumbien"
abbreviation: SESCiB
study_info:
  research_question: (1)  Schätzung des Anteils der Schulkinder und
    Jugendlichen mit diagnostizierten IgG- und IgM-Antikörpern gegen SARS-CoV-2. (2)
    Bestimmung des Anteils der asymptomatischen oder subklinischen Infektionen in
    SARS-CoV-2-positiven Personen.  (3) Erforschung sozialer, demografischer, wirtschaftlicher
    und klinischer Faktoren, die möglicherweise mit der Seropositivität bei Kindern und Jugendlichen verbunden sein können.
  diagnostic_test:
    - company: Luminex Corp.
      product: Point-of-care test
      type: ""
      antibody_classes:
        - IgM
        - IgG
  primary_outcomes: (1) Seroprävalenz von SARS-Cov-2, (2) Verhältnis asymptomatischer Infektionen, (3) Assoziierte klinische, sozioökonomische und demografische Faktoren.
  funding_sources: Helmholtz-Zentrum für Infektionsforschung (HZI)
  tested_antibody_classes:
    - IgG
    - IgA
recruitment:
  location:
    - place_name: Bogotá
      latitude: 4.624335
      longitude: -74.063644
  country:
    - Kolumbien
  type: randomisierte Ziehung von Personen die freiwillig an der Studie teilnehmen
  group: Kinder und Jugendliche
study_numbers:
  study_population: 1000
  population: 1200000
study_dates:
  sample_start: 2020-09
  sample_end: 2021-04
  study_start: 2020-06
  study_first_results: 2020-11
study_pi:
  name: Gérard Krause und Fernando Pio De La Hoz Restrepo
  institution: Helmholtz-Zentrum für Infektionsforschung (HZI) und Universidad Nacional de Colombia
  role: Professor
  email: serohub@helmholtz-hzi.de
team:
  - role: Studienleiter
    name: Gérard Krause
    institution: Helmholtz-Zentrum für Infektionsforschung (HZI)
    position: Leiter der Abteilung für Epidemiologie
    email: serohub@helmholtz-hzi.de
    title: Prof. Dr. med.
  - role: Studienleiter
    name: Fernando Pio De La Hoz Restrepo
    institution: Universidad Nacional de Colombia
    email: fpdelahozr@unal.edu.co
    title: Prof. MD. PhD
    position: Direktor Public Health Department, Medizinische Fakultät
  - institution: Helmholtz-Zentrum für Infektionsforschung (HZI)
    name: Tobias Kerrinnes
    role: Co-Studienleiter
    position: "Laborleiter"
    email: "tobis.kerrinnes@helmholtz-hzi.de"
    title: Dr.
  - name: Monika Strengert
    role: CCo-Studienleiter
    position: Laborleiter
    institution: Helmholtz-Zentrum für Infektionsforschung (HZI)
    email: ""
    title: Dr.
  - name: Johanna Carolina Torres Páez
    institution: Helmholtz-Zentrum für Infektionsforschung (HZI) und Universidad Nacional de Colombia
    email: Johanna.Torres@helmholtz-hzi.de
    role: Studienkoordinator
    position: Doktorand
    title: "MD. MSc. Sp Pediatrics. "
  - role: Studienkoordinator
    name: Nathalie Verónica Fernández Villalobos
    institution: Helmholtz-Zentrum für Infektionsforschung (HZI) und Universidad Nacional de Colombia
    email: ""
    position: Doktorand
    title: MSc.
study_coord:
  institution: Helmholtz-Zentrum für Infektionsforschung (HZI)
  name: Nathalie Verónica Fernández Villalobos
  role: Doktorand
  email: serohub@helmholtz-hzi.de
---

__Derzeit leider nur auf English:__

Some of the COVID-19 cases have been found to have no or only mild symptoms. Those asymptomatic cases can become a source of transmission of the virus, especially for vulnerable groups such as older adults or people with comorbidities. Due to that, it is important to estimate the real burden of the disease and to go beyond symptomatic cases.

## Study population
We propose a cross-sectional study to estimate SARS-CoV-2 seroprevalence in children and adolescents between 6 and 18 years old attending educational institutions at the city of Bogotá, Colombia. It also seeks to explore factors associated with SARS-CoV-2 seropositivity and symptomatology.

## Methodology
We designed a specific questionnaire for COVID-19 to collect information related to symptoms, exposure, and associated factors. Moreover, we are going to collect venous blood samples and to study the presence of antibodies to SARS-CoV-2 using a differential multiple serology.
 The diagnostic test is based on luminescence (Luminex) that would allow the detection of specific humoral immune responses in serum samples.

## Analysis
We propose a descriptive analysis of the data according sex, age and age groups, exposure, and self-reported symptoms. We are going to calculate the proportion of seropositive individuals, and the proportion of symptomatic and asymptomatic cases. We will perform univariate, bivariate, stratified and multivariate analysis, and will calculate measures of association.

## Insights
We consider that our results will have a significant impact on the knowledge of the epidemiology of SARS-CoV-2 in Colombia. It will provide information on the incidence of the virus in children and adolescents and will provide information on risk and protective factors.
